Filters: Keyword is Dogs [Clear All Filters]
1994
Helfand SC, Soergel SA, Donner RL, Gan J, Hank JA, Lindstrom MJ, Sondel PM.
1994. Potential to involve multiple effector cells with human recombinant interleukin-2 and antiganglioside monoclonal antibodies in a canine malignant melanoma immunotherapy model.. Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy. 16(3):188-97. Abstract
1995
Kurzman ID, MacEwen EG, Rosenthal RC, Fox LE, Keller ET, Helfand SC, Vail DM, Dubielzig RR, Madewell BR, Rodriguez CO.
1995. Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin.. Clinical cancer research : an official journal of the American Association for Cancer Research. 1(12):1595-601. Abstract
Panciera DL, Helfand SC, Soergel SA.
1995. Acute effects of continuous infusions of human recombinant interleukin-2 on serum thyroid hormone concentrations in dogs.. Research in veterinary science. 58(1):96-7. Abstract
Kisseberth WC, MacEwen EG, Helfand SC, Vail DM, London CL, Keller E.
1995. Response to liposome-encapsulated doxorubicin (TLC D-99) in a dog with myeloma.. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine. 9(6):425-8.
Vail DM, MacEwen EG, Kurzman ID, Dubielzig RR, Helfand SC, Kisseberth WC, London CA, Obradovich JE, Madewell BR, Rodriguez CO.
1995. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.. Clinical cancer research : an official journal of the American Association for Cancer Research. 1(10):1165-70. Abstract
1996
Teifke JP, Löhr CV.
1996. Immunohistochemical detection of P53 overexpression in paraffin wax-embedded squamous cell carcinomas of cattle, horses, cats and dogs.. Journal of comparative pathology. 114(2):205-10. Abstract
Helfand SC, Hank JA, Gan J, Sondel PM.
1996. Lysis of human tumor cell lines by canine complement plus monoclonal antiganglioside antibodies or natural canine xenoantibodies.. Cellular immunology. 167(1):99-107. Abstract
London CA, Kisseberth WC, Galli SJ, Geissler EN, Helfand SC.
1996. Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine mast cell tumours.. Journal of comparative pathology. 115(4):399-414. Abstract
1997







